Global & Asia Pacific Needle Free Injection System Market research report Competitive Landscape, segmentation, size, CAGR and Forecast 2017 to 2023 - Asia Pacific Market Research

Global & Asia Pacific Needle Free Injection System Market research report Competitive Landscape, segmentation, size, CAGR and Forecast 2017 to 2023

Sale

Global & Asia Pacific Needle Free Injection System Market research report Competitive Landscape, segmentation, size, CAGR and Forecast 2017 to 2023

$2,500$5,500

Clear
SKU: PH-20176 Category:
  • Report Description
  • Table of Content
  • Additional information

The Asia Pacific needle free injection system market is anticipated to grow at a CAGR of 16.5% during 2016 to 2022. The market has generated the revenue $ 2062 million in 2016 and is anticipated to reach up to $ 5143 million by 2022. Needle free technology is also called as jet injectors. It is widely used in mass vaccination programs for patients suffering from polio, smallpox, and measles, it keeps product supply cleaner. Needle free injection systems are new tradition by which a variety of medicines are introduced in patients without piercing the skin with the use of conventional needle. These systems functions on the mechanism in which medicine, in the form of liquid is forced with an eminent speed through a petite orifice that is held against the skin. Needle free injection system consists of technologies, which do not have a needle but make use of electrophoresis to drive drugs through the skin. This technology avoid several weakness associated with the conventional needle, such as risk of cross contamination from needle stick injury, injection site pain and eliminate negative needle issues. It communicates better reproducibility and fast drug delivery as compared to persistent drug delivery systems; hence it improves bioavailability in comparison to invasive drug delivery systems. One key difficulty with needle free injections is the witness concerned with residual vaccine on the skin surface.

As compare to the Asia Pacific region the global market of needle free injection system has estimated the revenue $ 9817 million in 2016 and is expected to make up to $ 23379 million by 2022. The market is anticipated to grow at a CAGR of 15.56% during 2016 to 2022 globally. The driver of the needle free injection system are increasing incidence of chronic diseases, and growing demand for self-injection devices. The major restraining factor of the needle free injection system is the alternative modes of drug delivery and it is not applicable for intravenous route. It is anticipated that about 70 percent of the diabetes-related deaths are expected to occur in developing countries in 2020. In China over 3 million people are dying by chronic non-communicable diseases each year. The rising demands for the biosimilars are the driving factor for the market, china’s recombinant biologic product sales estimated to be 40 % derived from biosimilars, which is valued at $1.5 billion.

The Asia pacific needle free injection system market is segmented on the basis of its end user, usability, application, site of delivery, type, technology, and product. The end user segment is divided into hospitals and clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies, other end users. The hospitals and clinics segment is anticipated to rise at the maximum rate in the forecast period. The growth in this segment can mostly be recognized with the advancement in the drug delivery or medication technology and rising geriatric population. The usability segment is divided into disposable needle-free injectors, and reusable needle-free injectors. On the basis of application segment, the market is segmented into Oncology, Insulin Delivery, Vaccine Delivery, Pain Management, and Other Applications. The vaccine delivery sub segment is anticipated to be the speediest-growing segment during forecast period. Due to the technological advancement, increasing incidence of chronic diseases, and growing preference for self-medication. On the basis of technology segment, the market is sub segmented into Jet-based needle-free injectors, vibration-based needle-free injectors, spring-based needle-free injectors, and laser-based needle-free injectors. The jet-based needle-free injectors are anticipated to provide the highest growth during the forecast period, due to their benefits in comparison with other injector systems. On the basis of site of delivery segment the needle free injection system is sub segmented into subcutaneous injectors, intramuscular injectors, and intradermal injectors.

 

On the basis of geography Asia Pacific needle free injection systems market is segmented into China, India, Korea, Japan, Australia, Thailand, and New Zealand. In the global prospect, the needle free injection systems market is dominated by North America, followed by Europe. In the Asia Pacific region china is the dominated market for needle free injection system, due to the high prevalence of chronic diseases in china, chronicnon-communicable diseases reports for the approximately 80% of total deaths in china. Regulatory support of novel injection system and increasing healthcare expenditure are major factors driving the market growth in Asia pacific market. The major players of the needle free injection systems are Asia Pharma Pharmaceutical Ltd, Astrazeneca, Bioject Medical Technologies, Crossject, Endo International Plc, Envision Pharma Group, Mylan, Merck, Pharmajet, Inovio Pharmaceuticals, Inc., And Medical International Technology Inc., National Medical Products, Inc., Valeritas, Inc. and Zogenix. Acquisition, merger, innovation and new product launch are the major strategies which help to sustain in the market. In 2016 Inovio Pharmaceuticals Inc. acquired Bioject Medical Technologies Inc.’s assets including devices, pioneering needle-free jet injection technology, and intellectual property, with the $5.5 million in cash and stock.

  1. INTRODUCTION
    • EXECUTIVE SUMMARY
    • ESTIMATION METHODOLOGY
  2. MARKET OVERVIEW
    • MARKET DEFINITION AND SCOPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • PORTERS 5 FORCE MODEL
    • KEY MARKET TRENDS
      • PIPELINE ANALYSIS
      • R & D SCENARIO
      • REGULATORY FRAMEWORK
    • PARAMETRIC ANALYSIS
    • KEY MARKET INSIGHTS
      • TOP 3 EMERGING COUNTRIES
      • TOP 3 REVENUE GENERATING SEGMENTS
      • TOP 3 EMERGING SEGMENTS
    • COMPETITIVE INTELLIGENCE
      • MARKET SHARE ANALYSIS
      • TOP WINNING STRATEGIES
      • CASE STUDY: TOP COMPETITIVE MOVES
    • STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
      • INVESTMENT OPPORTUNITIES BY REGIONS
      • OPPORTUNITIES IN EMERGING APPLICATIONS
      • INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
  1. MARKET DETERMINANTS
    • MARKET DRIVERS
      • INCREASING INCIDENCE OF CHRONIC DISEASES
      • RISING INCIDENCE OF COMMUNICABLE DISEASES
      • GROWING DEMAND FOR SELF-INJECTION DEVICES
      • ADVANTAGES OF DRUG DELIVERY TECHNOLOGY
    • MARKET RESTRAINTS
      • ALTERNATIVE MODES OF DRUG DELIVERY
      • NOT APPLICABLE FOR INTRAVENOUS ROUTE
    • MARKET OPPORTUNITIES
      • GROWING DEMAND FOR BIOSIMILARS AND VACCINATION
      • EMERGING MARKETS OF NEEDLE FREE INJECTION
    • MARKET CHALLENGES
      • NEED TO ENSURE SYSTEM STERILITY
      • HIGHER COST OF DEVELOPMENT
  1. MARKET SEGMENTATION
    • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY END USER 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY HOSPITALS AND CLINICS 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY HOME CARE SETTINGS 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY RESEARCH LABORATORIES 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY OTHER END USERS 2014 -2022 ($ MILLION)
    • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY USABILITY 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY DISPOSABLE NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY REUSABLE NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
    • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY APPLICATION 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY VACCINE DELIVERY  2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  INSULIN DELIVERY 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY ONCOLOGY 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY PAIN MANAGEMENT 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY OTHER APPLICATIONS 2014 -2022 ($ MILLION)
    • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY SITE OF DELIVERY 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY SUBCUTANEOUS INJECTORS2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  INTRAMUSCULAR INJECTORS 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY INTRADERMAL INJECTORS 2014 -2022 ($ MILLION)
    • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY TYPE 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY LIQUID-BASED NEEDLE-FREE INJECTORS2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY POWDER-BASED NEEDLE FREE INJECTORS 2014 -2022 ($ MILLION)
    • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY TECHNOLOGY2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY JET-BASED NEEDLE-FREE INJECTORS2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  SPRING-BASED NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY LASER-POWERED NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY VIBRATION-BASED NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
    • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY PRODUCTS 2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY FILLABLE NEEDLE-FREE INJECTORS2014 -2022 ($ MILLION)
      • APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  PREFILLED NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
  1. GEOGRAPHIC ANALYSIS
    • CHINA NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
    • INDIA NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
    • KOREA NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
    • JAPAN NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
    • AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
    • THAILAND NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
    • NEWZEALAND NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
    • REST OF ASIA PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
  2. GLOBAL VS APAC MARKET “A COMPARATIVE STUDY”
    • DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • OPPORTUNITY MATRIX
    • US VS APAC MARKET
    • EUROPE VS APAC MARKET
    • ROW VS APAC MARKET
  3. COMPANY PROFILES
    • ASIA PHARMA PHARMACEUTICAL LTD
    • ASTRAZENECA
    • BIOJECT MEDICAL TECHNOLOGIES
    • CROSSJECT
    • ENDO INTERNATIONAL PLC
    • ENVISION PHARMA GROUP
    • MYLAN
    • MERCK
    • PHARMAJET
    • INOVIO PHARMACEUTICALS INC.
    • MEDICAL INTERNATIONAL TECHNOLOGY INC.
    • INJEX PHARMA AG
    • NATIONAL MEDICAL PRODUCTS INC.
    • VALERITAS INC.
    • ZOGENIX

LIST OF TABLES

  1. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY END USER 2014 -2022 ($ MILLION)
  2. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY HOSPITALS AND CLINICS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  3. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY HOME CARE SETTINGS BY GEOGRAPHY 2014-2022, ($ MILLIONS)
  4. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY RESEARCH LABORATORIES 2014 -2022 ($ MILLION)
  5. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES BY GEOGRAPHY 2014 -2022 ($ MILLION)
  6. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY OTHER END USERS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  7. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY USABILITY 2014 -2022 ($ MILLION)
  8. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY DISPOSABLE NEEDLE-FREE INJECTORS GEOGRAPHY 2014 -2022 ($ MILLION)
  9. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY REUSABLE NEEDLE-FREE INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  10. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY APPLICATION 2014 -2022 ($ MILLION)
  11. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY VACCINE DELIVERY BY GEOGRAPHY 2014 -2022 ($ MILLION)
  12. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY INSULIN DELIVERY 2014 -2022 ($ MILLION)
  13. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY ONCOLOGY BY GEOGRAPHY 2014 -2022 ($ MILLION)
  14. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  PAIN MANAGEMENT BY GEOGRAPHY 2014 -2022 ($ MILLION)
  15. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  OTHER APPLICATIONS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  16. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  SITE OF DELIVERY2014 -2022 ($ MILLION)
  17. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  SUBCUTANEOUS INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  18. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  INTRAMUSCULAR INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  19. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  INTRADERMAL INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  20. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  TYPE 2014 -2022 ($ MILLION)
  21. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  LIQUID-BASED NEEDLE-FREE INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  22. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  23. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  POWDER-BASED NEEDLE FREE INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  24. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  TECHNOLOGY 2014 -2022 ($ MILLION)
  25. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  JET-BASED NEEDLE-FREE INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  26. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  SPRING-BASED NEEDLE-FREE INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  27. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  LASER-POWERED NEEDLE-FREE INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  28. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  VIBRATION-BASED NEEDLE-FREE INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  29. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY PRODUCT 2014 -2022 ($ MILLION)
  30. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  FILLABLE NEEDLE-FREE INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  31. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY  PREFILLED NEEDLE-FREE INJECTORS BY GEOGRAPHY 2014 -2022 ($ MILLION)

 

LIST OF FIGURE

  1. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY HOSPITALS AND CLINICS2014 -2022 ($ MILLION)
  2. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY HOME CARE SETTINGS2014 -2022 ($ MILLION)
  3. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY RESEARCH LABORATORIES2014-2022 ($ MILLIONS)
  4. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES 2014 -2022 ($ MILLION)
  5. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY OTHER END USERS  2014 -2022 ($ MILLION)
  6. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY DISPOSABLE NEEDLE-FREE INJECTORS2014 -2022 ($ MILLION)
  7. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY REUSABLE NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
  8. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY VACCINE DELIVERY 2014 -2022 ($ MILLION)
  9. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY INSULIN DELIVERY 2014 -2022 ($ MILLION)
  10. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY ONCOLOGY 2014 -2022 ($ MILLION)
  11. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY MEDIA AND ENTERTAINMENT 2014 -2022 ($ MILLION)
  12. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY PAIN MANAGEMENT 2014 -2022 ($ MILLION)
  13. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY OTHER APPLICATIONS 2014 -2022 ($ MILLION)
  14. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY   SUBCUTANEOUS INJECTORS 2014 -2022 ($ MILLION)
  15. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY INTRAMUSCULAR INJECTORS 2014 -2022 ($ MILLION)
  16. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY LIQUID-BASED NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
  17. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS2014 -2022 ($ MILLION)
  18. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY POWDER-BASED NEEDLE FREE INJECTORS 2014 -2022 ($ MILLION)
  19. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY JET-BASED NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
  20. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY SPRING-BASED NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
  21. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY LASER-POWERED NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
  22. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY VIBRATION-BASED NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
  23. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY FILLABLE NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
  24. APAC NEEDLE FREE INJECTION SYSTEM MARKET BY PREFILLED NEEDLE-FREE INJECTORS 2014 -2022 ($ MILLION)
  25. CHINA NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
  26. INDIA NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
  27. KOREA NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
  28. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)
  29. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET 2014 -2022 ($ MILLION)

Additional information

License Type

Single User APAC License, Single User Global License, Site License APAC, Site License Global